Aceragen
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15 Tw Alexander Dr Ste 418, Durham, Nort...Website
www.aceragen.comRevenue
$16.3 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Aceragen
Aceragen is a rare disease biopharmaceutical company. They address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a positive impact on the lives of patients and families. They are based in Research Triangle Park, North Carolina.Explore more
Popular SearchesAceragenAceragen IncAceragen AceragenIdera PharmaceuticalsSIC Code 28,283NAICS Code 32,325Show more
Aceragen Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aceragen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Aceragen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Aceragen has new funding data
Check if Aceragen has recently received funding, and reach out quickly before it becomes old news!
Check out if Aceragen is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Aceragen recently announced quarterly report
Click to see if Aceragen had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Aceragen
Product Launch: Get notified when Aceragen launches new products
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Aceragen as Masked Content
Find 2 more new buyers
Compare Similar Companies to Aceragen
Compare insights from companies similar to Aceragen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Aceragen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aceragen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aceragen.
Aceragen financials insights
Gather financial insights about Aceragen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$16.5M
Stock Offering
$27.7M
2014
Stock Offering
$40M
2015
Stock Offering
$86.3M
2016
Stock Offering
$50M
2017
Stock Offering
$46.8M
2019
Share Placement
$97.7M
2020
Share Placement
$20.7M
Aceragen Tech Stack
A closer look at the technologies used by Aceragen
Most Recent Scoops
Left Company
Executive Move
Mergers & Acquisitions (M&A)
Left Company
Executive Move
Left Company
Executive Move
Left Company
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aceragen
Sign Up For FreeTo access detailed company insights
Aceragen is a rare disease biopharmaceutical company. They address rare, orphan diseases that typically have no available treatment, and strive to develop novel therapies which can have a positive impact on the lives of patients and families. They are based in Research Triangle Park, North Carolina.... Read More
